BARRETT & COMPANY, INC. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 323 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARRETT & COMPANY, INC. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$6,714
-18.6%
3000.0%0.00%
-25.0%
Q1 2024$8,253
-9.8%
3000.0%0.00%
-20.0%
Q4 2023$9,147
-3.6%
3000.0%0.01%
-16.7%
Q3 2023$9,486
-22.5%
3000.0%0.01%
-14.3%
Q2 2023$12,234
+9.4%
3000.0%0.01%0.0%
Q1 2023$11,181
+6.8%
3000.0%0.01%0.0%
Q4 2022$10,4670.0%3000.0%0.01%0.0%
Q3 2022$10,4673000.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders